Additional panelists to be announced.
William McCormick, MBA
Chief Executive Officer, Medivance Billing Service, Inc.
William McCormick is a highly experienced healthcare professional with comprehensive skills in strategic planning, sales, operational management and implementation. Throughout his professional career, he has demonstrated the ability to lead diverse teams of professionals to new levels of success in the highly competitive healthcare industry. William has a proven ability to successfully analyze an organization’s critical business requirements, identify deficiencies and potential opportunities, and develop innovative and cost-effective solutions for enhancing competitiveness, increasing revenues, and improving customer service offerings.
With a master of Business Administration degree with a concentration in healthcare administration, “Bill” has traveled extensively serving clients in many facets of healthcare operations. Prior to entering the behavioral health industry, Bill operated one of Florida’s most successful medical equipment and home infusion pharmacy businesses which he sold to a national drug chain in 2002.
In the community, Mr. McCormick served as president of the Fort Lauderdale Branch NAACP where he championed the causes of justice, equality and job creation for local citizens. He was widely known as the civic leader who petitioned Governor Jeb Bush and received approval for the “first time in Florida’s history”, the extension of time for polls during the 2002 presidential election. William has been recognized by numerous organizations for his outstanding service and contributions throughout the United States and has recently been placed on the Florida Memorial University Board of Trustees.
Currently, William McCormick serves as chief operating officer for Medivance Billing Service, where since his appointment, client net collections has exceeded over $160 million dollars.
Tracy Griffin Collander, L.C.S.W.
Executive Director, Behavioral Health Care Accreditation
Tracy Griffin Collander, L.C.S.W. is the Executive Director of the Behavioral Health Care Accreditation program at The Joint Commission. In this role, she is the behavioral health product line leader responsible for tactical operations including product development and strategic planning. Ms. Griffin Collander serves as The Joint Commission liaison to national behavioral health professional and provider organizations.
Ms. Griffin Collander has more than 21 years of experience in behavioral health care as both a clinician and an executive director focusing on residential, day treatment, therapeutic day schools, foster care, in-home, and outpatient treatment programs. Immediately prior to joining The Joint Commission, Ms. Griffin Collander was the executive director of Gateway Foundation’s residential and outpatient programs in Aurora, Illinois, serving adults and youth in need of addiction and mental health treatment services.
Ms. Griffin Collander is a licensed clinical social worker in the state of Illinois. She received her master’s degree in social work from the School of Social Service Administration at the University of Chicago, and her bachelor’s degree in psychology from Gustavus Adolphus College in St. Peter, Minnesota.
David R. Gastfriend, MD., CEO
Chief Executive Officer at the Treatment Research Institute
Dr. Gastfriend is an addiction psychiatrist who completed his training at Massachusetts General Hospital (MGH). Throughout a 25-year span at Harvard Medical School and MGH he was Director of the MGH Addiction Research Program and founded the MGH/McLean Hospital Addiction Psychiatry Fellowship. His pharmacologic and behavioral research activities included serving as an investigator in the National Institute on Drug Abuse (NIDA) Cocaine Collaborative Study, and as investigator and committee chair in the National Institute on Alcohol Abuse and Alcoholism (NIAAA) COMBINE Study and the NIDA Clinical Trials Network. As the lead researcher on the American Society of Addiction Medicine’s (ASAM’s) Patient Placement Criteria, his efforts to operationalize and validate contributed to its endorsement by most U.S. states, the Veterans Administration and the Department of Defense. Dr. Gastfriend is also the Chief Architect of the ASAM Criteria Software, developed with the support of the U.S. Substance Abuse and Mental Health Services Administration for nationwide release. From 2004 to 2013, Dr. Gastfriend served as Vice President for Scientific Communications at Alkermes, Inc., where he directed scientific publications and presentations on clinical and health economic research in addiction. Dr. Gastfriend has more than 150 scientific publications including The ASAM Criteria and Addiction Treatment Matching books. He has advised the governments of China, Iceland, Israel, Norway, Russia and the U.S. on advances in alcohol and drug addiction treatment.
Dr. Gastfriend has received numerous awards including the NIDA Mid-Career Investigator Award for Patient-Oriented Research in 2000; the “Champion in Health Care – Innovator Award” from the Boston Business Journal for his research on Vivitrol® in 2007; and the ASAM’s McGovern Award and Lecture for contributions to addiction treatment and society.
Cory Mertz, M&AMI
Managing Partner, Mertz Taggart
Cory began his career at a Fortune 500 electronics manufacturing services provider, holding several operational and business development leadership positions, including managing the transition of multiple international acquisitions across Europe, South America and Mexico.
In 2006, Cory started his M&A career focusing solely on healthcare services businesses. Since then, Cory has had the opportunity to forge relationships with industry leaders and private equity groups throughout the country, having closed over 50 healthcare transactions, nationally.
Cory has been an invited speaker at several regional and national health care conferences on topics ranging from maximizing value for your company to the processes and pitfalls of selling a healthcare company.
Cory holds a BS in Mechanical Engineering magna cum laude from the University of Florida.